Junichi Taguchi
Director/Board Member bei EPS HOLDINGS, INC.
Profil
Junichi Taguchi is an Independent Director at EPS Holdings, Inc. and an Outside Director at Cancer Intelligence Care Systems, Inc. He previously worked as a Director at Tokyo Midtown Medicine Co., Ltd.
and as a Managing Director at Midtown Clinic Medical Corp.
He also served as an Independent Non-Executive Director at EPS Creative Health Technology Group Ltd.
from 2021 to 2024.
Additionally, he held the position of Associate Professor & Manager at Tokai University Hachioji Hospital.
Dr. Taguchi holds graduate and doctorate degrees from the University of Tokyo.
Aktive Positionen von Junichi Taguchi
Unternehmen | Position | Beginn |
---|---|---|
EPS HOLDINGS, INC. | Director/Board Member | 20.12.2019 |
Cancer Intelligence Care Systems, Inc.
Cancer Intelligence Care Systems, Inc. Medical SpecialtiesHealth Technology Part of Resorttrust, Inc., Cancer Intelligence Care Systems, Inc. is a Japanese company that manufactures and sells medical equipment. The private company is based in Tokyo, Japan and was founded in 2005. | Director/Board Member | 01.01.2020 |
Ehemalige bekannte Positionen von Junichi Taguchi
Unternehmen | Position | Ende |
---|---|---|
EPS CREATIVE HEALTH TECHNOLOGY GROUP LIMITED | Director/Board Member | 01.04.2024 |
Midtown Clinic Medical Corp. | Chief Executive Officer | - |
Tokyo Midtown Medicine Co., Ltd. | Director/Board Member | - |
Tokai University Hachioji Hospital | Corporate Officer/Principal | - |
Ausbildung von Junichi Taguchi
University of Tokyo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EPS CREATIVE HEALTH TECHNOLOGY GROUP LIMITED | Consumer Non-Durables |
Private Unternehmen | 5 |
---|---|
EPS Holdings, Inc.
EPS Holdings, Inc. BiotechnologyHealth Technology EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin, and Others. The CRO segment offers clinical trials, data management, and statistical analysis. The SMO segment enters into contracts with medical institutions to conduct clinical trials. The CSO segment provides drug information and awareness for medical and pharmaceutical industries. The Global Research segment provides consignment services through its subsidiary for multilateral clinical trials in Asia-Pacific. The Ekishin segment focuses on medical equipment, pharmaceutical and investment related businesses through its Japan and China based subsidiaries. The Others segment provides various services related to management of clinical research from business processing outsource business related to medicine and medical care. The company was founded on May 30, 1991 and is headquartered in Tokyo, Japan. | Health Technology |
Tokai University Hachioji Hospital | |
Tokyo Midtown Medicine Co., Ltd. | |
Cancer Intelligence Care Systems, Inc.
Cancer Intelligence Care Systems, Inc. Medical SpecialtiesHealth Technology Part of Resorttrust, Inc., Cancer Intelligence Care Systems, Inc. is a Japanese company that manufactures and sells medical equipment. The private company is based in Tokyo, Japan and was founded in 2005. | Health Technology |
Midtown Clinic Medical Corp. |